EUROIMMUN’s CE-marked SARS-CoV-2 NeutraLISA provides fast PRODUCT detection of SARS-CoV-2 neutralising antibodies
The new CE-marked SARS-CoV-2 NeutraLISA from EUROIMMUN provides fast and economical determination of the inhibiting effect of anti- SARS-CoV-2 antibodies in patient samples, serving as a surrogate virus neutralisation test.